Euronext N.V. : The upward trend should continue
Entry price | Target | Stop-loss | Potential |
---|
€99.1 |
€110 |
€95 |
+11% |
---|
Market participant are once again showing interest in shares in Euronext N.V.. The technical chart pattern now appears positive for the short term with new upside potential.
Strengths● Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses● The company's earnings growth outlook lacks momentum and is a weakness.
● One of the major weak points of the company is its financial situation.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
Surperformance is Buy on EURONEXT N.V. since 2023-10-11
.